Aspirin-exacerbated respiratory disease (AERD) is nonatopic asthma, and the role of heat shock protein (HSP) 70 in AERD remains unknown. We analyzed HSP70 gene polymorphisms in Japanese patients with AERD.
Methods
The single-nucleotide polymorphisms in HSPA1B-179C>T and 1267A>G gene were examined in patients with AERD and those with aspirin-tolerant asthma (ATA). All patients were in a stable condition.
Results
There were significant differences in total serum IgE levels, peripheral blood eosinophil count, and prevalence of atopy between AERD and ATA. The patients with AERD showed higher frequencies of the CT/TT genotype of the HSPA1B-179C>T than that of the CC genotype compared to ATA (P < 0.001). They showed higher frequencies of the GG genotype of the HSPA1B1267A>G than that of the GA/AA genotype compared to ATA (P < 0.001). These differences were irrespective of the sex for the genotypes analyzed. The frequency of HSPA1B-179C/1267A haplotype was significantly higher in AERD compared to ATA (P < 0.001; odds ratio, 3.154; 95% confidence interval, 1.916-5.193). Among the clinical and hematological characteristics investigated, AERD showed a significant variance in peripheral blood eosinophil count according to the association of the 2 HSP70 gene polymorphisms (P = 0.033), but not in ATA.
Conclusions
Our findings first suggest that the association between HSPA1B-179C>T and 1267A>G gene sequence variations might be implicated in the development of AERD.
KiangJG, TsokosGC.Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol Ther. 1998; 80: 183–201.
2.
SistonenL, SargeKD, MorimotoRI.Human heat shock factors 1 and 2 are differentially activated and can synergistically induce hsp70 gene transcription. Mol Cell Biol. 1994; 14: 2087–2099.
3.
MartinsGA, DavidCM, MitchellC, . Expression of heat shock protein 70 in leukocytes of patients with sepsis. Int J Mol Med. 1999; 3: 401–404.
4.
MilnerCM, CampbellRD.Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics. 1990; 32: 242–251.
5.
HunatC, MorimotoRI.Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70. Proc Natl Acad Sci U S A. 1985; 82: 6455–6459.
6.
ItoY, AndoA, AndoH, . Genomic structure of the spermatid-specific hsp70 homologue gene located in the class III region of the major histocompatibility complex of mouse and man. J Biochem (Tokyo). 1998; 124: 347–353.
7.
WatererGW, ElbaahlawanL, QuansneyMW, . Heat shock protein 70-2+1267 AA homozygotes have an increased risk of septic shock protein in adults with community-acquired pneumonia. Crit Care Med. 2003; 31: 1367–1372.
8.
TempleSEL, CheongKY, ArdlieKG, . The septic shock associated HSPA1B1267 polymorphism influences production of HSPA1A and HSPA1B. Intensive Care Med. 2004; 30: 1761–1767.
9.
KeeC, CheongKY, PhamK, . Genetic variation in heat shock protein 70 is associated with septic shock: narrowing the association to a specific haplotype. Int J Immunogenet. 2008; 35: 465–473.
10.
StevensonDD, Sanchez-BorgesM, SzczeklikA.Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol. 2001; 87: 177–180.
11.
SchaferD, MauneS.Pathogenic mechanisms and in vitro diagnosis of AERD. J Allergy (Cairo). 2012; 2012: 789232.
12.
SanakM, SimonHU, SzczeklikA.Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet. 1997; 350: 1599–1600.
13.
KawagishiY, MitaH, TaniguchiM, . Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. J Allergy Clin Immunol. 2002; 109: 936–942.
14.
KimSH, BaeJS, SuhCH, . Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness. Allergy. 2005; 60: 760–765.
15.
KimSH, OhJM, KimYS, . Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin Exp Allergy. 2006; 36: 433–439.
16.
Van SambeekR, StevensonDD, BaldasaroM, . 5′ Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol. 2000; 106: 72–76.
17.
ChoiJH, ParkHS, OhHB, . Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with haplotype of 5-lipoxygenase. Hum Genet. 2004; 114: 337–344.
18.
HigashiN, MitaH, OnoE, . Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers. J Allergy Clin Immunol. 2010; 125: 1084–1091.
19.
MayA, WeberA, GallH, . Means of increasing sensitivity of an in vitro diagnostic test for aspirin intolerance. Clin Exp Allergy. 1999; 29: 1402–1411.
20.
SchaferD, SchmidM, GodeUC, . Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics. Eur Respir J. 1999; 13: 638–646.
21.
de WeckAL, SanzML.Celluler allergen stimulation test (CAST) 2003, a review. J Investig Allergol Clin Immunol. 2004; 14: 253–273.
22.
SanzML, GamboaP, de WeckAL.A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol. 2005; 136: 58–72.
23.
GrayPA, WarnerTD, VojnovicI, . Effects of non-steroidal anti-inflammatory drugs on cyclooxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors. Br J Pharmacol. 2002; 137: 1031–1038.
24.
KohyamaK, AbeS, KodairaK, . Arg16Gly β2-adrenergic receptor gene polymorphism in Japanese patients with aspirin-exacerbated respiratory disease. Int Arch Allergy Immunol. 2011; 156: 405–411.
25.
KohyamaK, AbeS, KodairaK, . Polymorphisms of the CYP2C19 gene in Japanese patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2011; 128: 1117–1120.
26.
KohyamaK, AbeS, KodairaK, . IL-13 and IL-17A gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2011; 107: 510–516.
27.
KohyamaK, HashimotoM, AbeS, . Thromboxane A2 receptor +795T>C and chemoattractant receptor-homologous molecule expressed on Th2 cells −466T>C gene polymorphisms in patients with aspirin-exacerbated respiratory disease. Mol Med Report. 2012; 5: 477–482.
28.
VignolaAM, ChanezP, PollaBS, . Increased expression of heat shock protein 70 on airway cells in asthma and chronic bronchitis. Am J Respir Cell Mol Biol. 1995; 13: 683–691.
29.
BertorelliG, BocchinoV, XiasongZ, . Heat-shock protein 70 upregulation is related to HLA-DR expression in bronchial asthma. Effects of inhaled glucocorticoids. Clin Exp Allergy. 1998; 28: 551–560.
30.
PollaBS, BacheletM, Dall'AvaJ, . Heat-shock proteins in inflammation and asthma: Dr Jekyll or Mr Hyde?Clin Exp Allergy. 1998; 28: 527–529.
31.
AronY, BussonM, PollaBS, . Analysis of hsp70 gene polymorphism in allergic asthma. Allergy. 1999; 54: 165–170.
32.
PaganelliR, AnsoteguiIJ, SastreJ, . Specific IgE antibodies in the diagnosis of atopic disease. Allergy. 1998; 53: 763–768.
33.
LindenCC, MisiakRT, WegienkaG, . Analysis of allergen specific IgE cut points to cat and dog in the Childhood Allergy Study. Ann Allergy Asthma Immunol. 2011; 106: 153–158.
34.
LiSS, KhalidN, CarlsonC, . Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. Biostatistics. 2003; 4: 513–522.
35.
ZaoLP, LiSS, KhalidN.A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies. Am J Hum Genet. 2003; 72: 1231–1250.
36.
SmithRS, MeyersDA, PetersSP, . Sequence analysis of HSPA1A and HSPA1B in a multi-ethnic study population. DNA Seq. 2007; 18: 47–53.
37.
MilnerCM, CampbellRD.Polymorphic analysis of the three MHC-linked HSP70 genes. Immunogenetics. 1992; 36: 357–362.
38.
SampsonAP, CowburnAS, SladekK, . Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients. Int Arch Allergy Immunol. 1997; 113: 355–357.
39.
SzczeklikA, NizankowskaE, DuplagaM.Natural history of aspirin-induced asthma. AIANE Investigators. European network on aspirin-induced asthma. Eur Respir J. 2000; 16: 432–436.
40.
AbererW, BircherA, RomanoA, . Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003; 58: 854–863.
41.
BuhlT, MeynbergHC, KauneKM, . Long-term follow-up of patients with hypersensitivity to nonsteroidal anti-inflammatory drugs reveals shortcomings in compliance and care. J Allergy Clin Immunol. 2011; 127: 284–285.
42.
FawcettTW, XuQ, HolbrookNJ.Potentiation of heat stress-induced hsp70 expression in vivo by aspirin. Cell Stress Chaperones. 1997; 2: 104–109.
43.
AmiciC, RossiA, SantotoMG.Aspirin enhances thermotolerance in human erythroleukemic cells: an effect associated with the modulation of the heat shock response. Cancer Res. 1995; 55: 4452–4457.
44.
GehrmannM, BrunnerM, PfisterK, . Differential up-regulation of cytosolic and membrane-bound heat shock protein 70 in tumor cells by anti-inflammatory drugs. Clin Cancer Res. 2004; 10: 3354–3364.
45.
MortazE, RedegeldFA, BloksmaN, . Induction of HSP70 is dispensable for anti-inflammatory action of heat shock or NSAIDs in mast cells. Exp Hematol. 2006; 34: 414–423.
46.
MortazE, RedegeldFA, NijkampFP, . Acetylsalicylic acid–induced release of HSP70 from mast cells results in cell activation through TLR pathway. Exp Hematol. 2006; 34: 8–18.
47.
ReuterS, HeinzA, SierenM, . Mast cell-derived tumor necrosis factor is essential for allergic airway disease. Eur Respir J. 2008; 31: 773–782.
48.
OettgenHC.Mast cells and tumor necrosis factor alpha (TNF-α) partners in crime in asthma pathogenesis. Clin Immunol. 2011; 140: 1–2.
49.
LukacsNW, StrieterRM, ChensueSW, . TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation. J Immunol. 1995; 154: 5411–5417.
50.
MailletI, Schnyder-CandrianS, CouillinI, . Allergic lung inflammation is mediated by soluble tumor necrosis factor (TNF) and attenuated by dominant-negative TNF biologics. Am Respir Cell Mol Biol. 2011; 45: 731–739.
51.
AdamjeeJ, SuhYJ, ParkHS, . Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma. J Pathol. 2006; 209: 392–399.
52.
O'SullivanS, DahlenB, RoquetA, . Urinary 9 alpha, 11 beta-PGF2 as a marker of mast cell activation in allergic and aspirin-intolerant asthma. Adv Exp Med Biol. 1997; 433: 159–162.
53.
O'SullivanS, DahlenB, DahlenSE, . Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol. 1996; 98: 421–432.
54.
MortazE, EngelsF, NijikampFP, . New insights on the possible role of mast cells in aspirin-induced asthma. Curr Mol Pharmacol. 2009; 2: 182–189.
55.
ZanderKA, SaavedraMT, WestJ, . Protein microarray analysis of nasal polyps from aspirin-sensitive and aspirin-tolerant patients with chronic rhinosinusitis. Am J Rhinol Allergy. 2009; 23: 268–272.
